Kiniksa Pharmaceuticals International, plc (KNSA) Revenue by Year

KNSA

Kiniksa Pharmaceuticals International, plc generated $677.6M in revenue in fiscal year 2025. This represents an increase of 60.1% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to $754.0M in revenue. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Kiniksa Pharmaceuticals International, plc has filed alongside them.

FY2025 annual

Revenue $677.6M

YoY +60.1%

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Apr 28, 2026 Currency USD

Annual figures, oldest first. Point at a bar to read its period.

KNSA Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K
Revenue	$754.0M	$677.6M+60.1%	$423.2M+56.6%	$270.3M+22.7%	$220.2M+471.2%	$38.5M	N/A	N/A	N/A	N/A

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

KNSA Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

Metric	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q	Q2'2310-Q
Revenue	$214.3M+55.5%	$202.1M+65.0%	$180.9M+61.2%	$156.8M+44.3%	$137.8M+72.5%	$122.5M+46.9%	$112.2M+67.4%	$108.6M+52.0%	$79.9M+65.2%	$83.4M+34.8%	$67.0M-32.4%	$71.5M+165.0%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Kiniksa Pharmaceuticals International, plc financials

Frequently Asked Questions

What was Kiniksa Pharmaceuticals International, plc's revenue in fiscal year 2025?

Kiniksa Pharmaceuticals International, plc generated $677.6M in revenue in fiscal year 2025.

How fast is Kiniksa Pharmaceuticals International, plc's revenue growing?

Kiniksa Pharmaceuticals International, plc (KNSA) revenue rose by 60.1% year over year, from $423.2M to $677.6M in fiscal year 2025.

What is Kiniksa Pharmaceuticals International, plc's revenue over the last twelve months?

Kiniksa Pharmaceuticals International, plc (KNSA) reported $754.0M in revenue over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

What was Kiniksa Pharmaceuticals International, plc's revenue in the most recent quarter?

Kiniksa Pharmaceuticals International, plc (KNSA) reported $214.3M in revenue in Q1 2026. This represents an increase of 55.5% from the same quarter a year earlier.

What does revenue mean on a financial statement?

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Kiniksa Pharmaceuticals International, plc (KNSA) reported on that line in every period on record.